Past Events

Presentation Ernst Berndt: Pricing and Reimbursement in US Pharmaceutical Markets

Presentation Adam Kolber’s paper: The Experiential Future of the Law

Presentation Rebecca Eisenberg: Patents and Regulatory Exclusivity

Presentation David Hyman’s paper: Employment-Based Health Insurance: Is Health Reform a Game Changer?

Peter Barton Hutt, Senior Counsel, Covington & Burling, LLP and Lecturer on Law at Harvard Law School, and Bruce A. Leicher, Senior Vice President and General Counsel at Momenta Pharmaceuticals discussed and debated emerging issues related to this topic

Presentation Nir Eyal: Deep exclusionary reasons: the case of luck egalitarianism and personal responsibility for health

This panel focused on how patent law affects various industries differently. The pharmaceutical and high-tech industries offer perhaps the most vivid examples of this divergence. Panelists discussed whether patent law currently is or should be technology specific, and also explored questions concerning which institutional actor would be in the best position to craft substantive patent…

Conference Description In the “Introductory Lectures on Psychoanalysis,” Sigmund Freud famously suggested that humanity would suffer three great blows at the hand of science: “The first was when they learnt that our earth was not the center of the universe but only a tiny fragment of a cosmic system of scarcely imaginable vastness. This is…

This panel discussion examined how developments in evolutionary biology and the mind sciences should inform law, philosophy, and economics, and focused on subjects such as punishment, responsibility, racism, addiction, and cooperation. Participants included I. Glenn Cohen, Joshua Greene, William Fitzpatrick, Adina Roskies, Walter Sinnott-Armstrong, and Thomas Scanlon.

In previous years, the regulation of stem cell research has been a politically controversial topic. However the change from the Bush to the Obama administration presented potentially substantial changes in the regulatory environment for stem cell research, with far reaching implications for the important though controversial technology. Petrie-Flom convened a group of leading scholars and…